<DOC>
	<DOCNO>NCT01084473</DOCNO>
	<brief_summary>The aim study determine effect dexmedetomidine infusion gastric empty oro-caecal transit time healthy volunteer , judge measure plasma paracetamol concentration paracetamol ingestion pulmonary hydrogen measurement technique lactulose ingestion . The effect dexmedetomidine compare effect morphine placebo .</brief_summary>
	<brief_title>Effect Dexmedetomidine Gastric Emptying Gastrointestinal Transit</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Normal cognitive function fluent skill Finnish language order able give inform consent communicate study personnel Age ≥ 18 year . Male gender . Weight ≥ 60 kg . Written inform consent subject . Previous history intolerance study drug related compound additive . Concomitant drug therapy kind except ibuprofen 14 day prior study day . Existing recent significant disease . History haematological , endocrine , metabolic gastrointestinal disease . History asthma kind drug allergy . Previous present alcoholism , drug abuse , psychological emotional problem likely invalidate inform consent , limit ability subject comply protocol requirement . A positive test result urine toxicology . A `` yes '' answer question modify Finnish version Abuse Questions Donation blood within six week prior study . Special diet lifestyle factor would compromise condition study interpretation result . BMI &gt; 30 kg / m2 . Participation clinical study involve investigational market drug product concomitantly within one month prior entry study . Smoking one month start study study period . Clinically significant abnormal finding physical examination , ECG laboratory screen [ routine haematology ( haemoglobin , haematocrit , red blood cell count , white blood cell count , platelet ) , renal function test ( creatinine , urea ) liver function test ( bilirubin ) ] .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>gastric empty</keyword>
	<keyword>oro-cecal transit time</keyword>
	<keyword>Sedation intensive care</keyword>
	<keyword>Gastrointestinal effect sedation</keyword>
</DOC>